Several determining factors are involved in HPV infection outcomes; human leukocyte antigen (HLA) polymorphisms have been described as related factors. This study has ascertained the effect of genetic variation on HLA-DRB1 and DQB1 genes on HPV-16/-18/-31/-33/-45 and-58 clearance and redetection in Colombian women. PCR and qPCR were used for viral identification and the Illumina MiSeq system was used for HLA-typing of cervical samples (n = 276). Survival models were adjusted for identifying alleles/haplotypes related to HPV clearance/redetection; L1/L2 protein-epitope binding to MHC-II molecules was also predicted. Significant associations suggested effects favouring or hampering clearance/redetection events depending on the viral type involved in infection, e.g. just DRB1*12:01:01G favoured HPV-16 (coeff: 4.8) and HPV-45 clearance (coeff: 12.65) whilst HPV-18 (coeff: 2E-15), HPV-31 (coeff: 8E-17) and HPV-58 hindered elimination (coeff: 1E-14). An effect was only observed for some alelles when configured as haplotypes, e.g. DRB1*04:07:01G (having the greatest frequency in the target population) was associated with DQB1*02:01:1G or *03:02:03. Epitope prediction identified 23 clearance-related peptides and 29 were redetection-related; eight might have been related to HPV-16/-18 and-58 persistence and one to HPV-18 elimination. HLA allele/haplotype relationship with the course of HPV infection (clearance/redetection) depended on the infecting HPV type, in line with the specific viral epitopes displayed. Human papilloma virus (HPV) is the most common sexually-transmitted viral infection, having around 291 million infections annually 1-3. The causal relationship between persistent high-risk types of human papillomavirus (HR-HPV) infections and the development of cervical lesions progressing to cervical cancer (CC) has been extensively demonstrated 4,5. Many infections (around 90%) are eliminated during an average period of 2 years; however, some of them are latent as non-productive infection is limited to the epithelium's base layer and they do not become detected 6,7. A complex interaction between viral and host factors is responsible for CC's clinical course and development 8,9. Host immunological and genetic factors play an essential role in HPV infection outcome 10,11. Human leukocyte antigen (HLA) system alleles and haplotypes have been reported as being responsible for antigen presentation, recognition of infected cells and HPV elimination 12,13. Some HLA alleles and haplotypes have been described as being associated with CC, such as DRB1*07:02, DRB1*13:01, DQA1*01:03 and DQB1*06:03 14-16. However, most reports contain inconsistencies given the differences in the populations being analysed, the typing techniques, the outcomes considered and the methodological design 11,15,17-19. Few longitudinal studies have evaluated these molecules' association with HPV's natural history